StemWave

StemWave

Overview

About StemWave

Simplify's Rating
Why StemWave is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Short sessions fit high-throughput, cash-pay clinic models.
  • Broad application across shoulder, spine, hip, knee, ankle, and foot.
  • Education partnerships can strengthen clinician credibility and referral trust.

What critics are saying

  • Broad pain-relief claims invite scrutiny if outcomes miss marketing expectations.
  • Cash-pay pricing limits adoption when patients resist out-of-pocket treatment plans.
  • Competitors can imitate the clinician-channel playbook without exclusive distribution advantages.

What makes StemWave unique

  • FDA-listed, non-invasive focused wave therapy for musculoskeletal care.
  • Partnered with SSRP's vetted Trusted Partner Network in April 2026.
  • Provider training and clinic workflow focus support adoption across orthopedic settings.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Company News

The SSRP Institute
Apr 13th, 2026
SSRP Institute Welcomes StemWave as New Trusted Partner.

SSRP Institute Welcomes StemWave as New Trusted Partner. SSRP Institute PARTNER ANNOUNCEMENT. WILLOUGHBY, Ohio, [April 9, 2026] - The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP's internal review process. StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, modulation of inflammatory signaling, and activation of the body's natural repair processes. It is commonly applied across soft tissue and joint-related conditions involving the shoulder, spine, hip, knee, ankle, foot, and associated tendons and ligaments. "StemWave's focused shockwave therapy has delivered exceptional clinical outcomes in my regenerative practice, with its ability to enhance tissue regeneration and activate natural healing. Their evidence-based approach and commitment to clinical excellence make them an ideal partner for the SSRP community," said Dr. Gerald Morris, SSRP nominating Member. From a cellular perspective, acoustic wave therapy influences microvascular perfusion, mechanotransduction pathways, and tissue remodeling. Research in shockwave therapy demonstrates improved blood flow and inflammation modulation, aligning with treatment goals for chronic pain and soft tissue dysfunction. Treatments are brief, non-pharmacologic, and designed to complement comprehensive regenerative care plans. "Rooted in science and performance, SSRP is spearheading a cultural shift in healthcare," says Jake Ellis of StemWave. "The values and transparency of this community made it an obvious partnership for us at StemWave! We're thrilled and grateful to amplify SSRP's mission with practical, evidence-driven tools, further fueling the highest standards in clinician support and patient outcomes." Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice. About the SSRP Institute. The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care. The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP's educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices. RELATED RESOURCES Continue exploring related topics. Cellular Medicine Mondays Apr 13, 2026 Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients Preview Only Journal Club - Episode 083 Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link) Cellular Medicine Mondays Apr 6, 2026 Ep. 082 - April '26 Preview Only Dr. Seeds' Office Hours - Episode 082 Mastermind Mastermind 15: The Aesthetic Matrix This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You'll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and... 10 Lessons 17 hrs 24 min Cellular Medicine Mondays Mar 30, 2026 Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1) Preview Only Rabbit Holes - Episode 081 The Cellular Impact of UVA vs. UVB Light (Part 1) In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure. Medivive Mar 27, 2026 SSRP Institute Welcomes Medivive as New Trusted Partner PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [March 27, 2026] - The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP's mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD[+] therapy designed to support cellular energetics through sterile, clinician-prescribed formulations [...] William Seeds, MD Mar 25, 2026 The Truth about Ketone Esters: Not All Exogenous Products are the Same The Father of Ketones and the Value of Exogenous Ketone Esters I've talked about ketones and ketone esters for many years, and I've now come to a place where I really have to take a more direct stand on how they've been marketed to the wider public, and in particular, to providers who may not [...] Cellular Medicine Mondays Mar 23, 2026 Ep. 080 - BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms Preview Only Dissecting Protocols - Episode 080 BPC-157 vs. TB-500: Evaluating Unexpected Joint Symptoms Dr. Seeds reviews a case of swelling, joint stiffness, and tingling that appeared after stacking BPC-157 with TB-500, using it as a framework for thinking through peptide reactions, sourcing, and causality. (Question Link) Cellular Medicine Mondays Mar 16, 2026 Ep. 079 - Sleep Through the Lens of Cellular Medicine Preview Only Rabbit Holes - Episode 079 Sleep Through the Lens of Cellular Medicine In this episode of Rabbit Holes, Dr. Seeds discusses how light exposure, thermal regulation, and autonomic signaling influence sleep, circadian rhythm, and mitochondrial health through the lens of cellular medicine. SSRP Institute Mar 11, 2026 SSRP Institute Announces Troscriptions as New Trusted Partner PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [Mar 11, 2026] - The SSRP Institute today announced the addition of Troscriptions as its newest Trusted Partner, following nomination by SSRP Fellow Dr. Elizabeth Yurth and upon completion of the organization's internal clinical review and vetting process. Troscriptions offers physician-formulated, pharmaceutical grade, precision-dosed health optimization formulations delivered through a buccal [...] Cellular Medicine Mondays Mar 9, 2026 Ep. 078 - The Effects of AG1(R) Supplementation on the Gut Microbiome of Healthy Adults Preview Only Journal Club - Episode 078 The Effects of AG1(R) Supplementation on the Gut Microbiome of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Dr. Seeds reviews a randomized controlled study on AG1 and its potential impact on the gut microbiome. The research shows short-term probiotic survival and safety but no significant changes in microbiome diversity or systemic metabolic effects. Dr. Seeds discusses what the study supports, what it doesn't, and why careful interpretation of research matters in clinical practice. (Article Link) Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

Recently Posted Jobs

Sign up to get curated job recommendations

StemWave is Hiring for 11 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →